TAC congratulates Kenyan activists for their work to combat the 2008 Anti-Counterfeit Act in Kenya.  If adopted, the Act would have severely compromised medicine access in Kenya by including vague definitions of counterfeit medicines that could extend to generic medicines. If adopted as written, the act would have allowed authorities to seize generic medicine under the pretence of protecting the public from counterfeit medicines.

The Kenyan High Court order a review of the Act to remove any ambiguity that would allow the seizure of generic medicine, explicitly stating that “The right to life, dignity and health of the petitioners must take precedence over the intellectual property rights of patent holders.”

The full ruling can be found here